scholarly article | Q13442814 |
P50 | author | Faiez Zannad | Q19631268 |
Patrick Rossignol | Q33103963 | ||
Costantino Del Giudice | Q41811165 | ||
Pierre-Yves Courand | Q56954075 | ||
Daniel Herpin | Q125201195 | ||
Guillaume Bobrie | Q125201238 | ||
Caroline Dourmap | Q125201362 | ||
Thierry Denolle | Q125201445 | ||
DENERHTN Investigators | Q125201638 | ||
Pierre Lantelme | Q125201649 | ||
P2093 | author name string | Gilles Chatellier | |
Philippe Gosse | |||
Jean-Jacques Mourad | |||
Claire Mounier-Vehier | |||
Marc Sapoval | |||
Pascal Delsart | |||
Xavier Girerd | |||
Helena Pereira | |||
Olivier Ormezzano | |||
Jean Michel Halimi | |||
Michel Azizi | |||
Matthieu Monge | |||
Beatrice Bouhanick | |||
Jean Ribstein | |||
Bernard Vaisse | |||
Emile Ferrari | |||
Arshid Azarine | |||
P2860 | cites work | Mechanisms of arterial calcifications and consequences for cardiovascular function | Q26821993 |
A controlled trial of renal denervation for resistant hypertension | Q28236994 | ||
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry | Q31159429 | ||
Blood pressure and vascular calcification | Q33742676 | ||
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values' | Q34166955 | ||
Renal dysfunction complicating the treatment of hypertension | Q34977338 | ||
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial | Q34994094 | ||
Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study | Q35966462 | ||
Physiology in perspective: The Wisdom of the Body. Neural control of the kidney | Q36232564 | ||
Vascular and renal hemodynamic changes after renal denervation | Q36980327 | ||
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
The Cardiovascular Continuum extended: Aging effects on the aorta and microvasculature | Q37807824 | ||
Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis | Q38016284 | ||
Diagnostic and therapeutic problems of isolated systolic hypertension | Q38271627 | ||
Renal denervation for treatment of drug-resistant hypertension | Q38281699 | ||
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). | Q38381881 | ||
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial | Q38388222 | ||
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design | Q38492034 | ||
Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges | Q38688897 | ||
Renal Denervation: a Field in Flux. | Q38849320 | ||
Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension | Q40930739 | ||
Aorta calcification burden: Towards an integrative predictor of cardiac outcome after transcatheter aortic valve implantation | Q40966248 | ||
Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality | Q43546639 | ||
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension | Q44557638 | ||
Diastolic blood pressure, aortic atheroma, and prognosis in hypertension: new insights into a complex association. | Q44564476 | ||
Multimodality imaging of subclinical aortic atherosclerosis: relation of aortic stiffness to calcification and plaque in female twins. | Q45408758 | ||
Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension | Q46081526 | ||
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | Q46480414 | ||
Comparison of the Complior Analyse device with Sphygmocor and Complior SP for pulse wave velocity and central pressure assessment | Q50052751 | ||
The effect of renal denervation on kidney oxygenation as determined by BOLD MRI in patients with hypertension. | Q51666289 | ||
Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation. | Q52875447 | ||
Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. | Q53371967 | ||
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. | Q53632976 | ||
Renal simplicity denervation reduces blood pressure and renal injuries in an obesity-induced hypertension dog model. | Q54309875 | ||
Does the presence of accessory renal arteries affect the efficacy of renal denervation? | Q54701098 | ||
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. | Q55374393 | ||
Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension | Q58377856 | ||
Effect of renal denervation on dynamic autoregulation of renal blood flow | Q76353695 | ||
P433 | issue | 10 | |
P921 | main subject | hemodynamics | Q1642137 |
P577 | publication date | 2017-10-10 | |
P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
P1476 | title | Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial | |
P478 | volume | 6 |
Q55215861 | Blood Pressure and Renal Responses to Orthostatic Stress Before and After Radiofrequency Renal Denervation in Patients with Resistant Hypertension. |
Q91893651 | Device-based therapies for arterial hypertension |
Q88871710 | Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial |
Q90211918 | Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient |
Q92618289 | Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure |
Q89884921 | Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload |
Q57811572 | Predictors for success in renal denervation-a single centre retrospective analysis |
Q52808179 | Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial. |
Search more.